|
Volumn 79, Issue 6, 2008, Pages 615-
|
Timing the initiation of treatment in Parkinson's disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASAL GANGLION;
BRADYKINESIA;
DISEASE COURSE;
DOPAMINERGIC NERVE CELL;
EDITORIAL;
NERVE DEGENERATION;
NERVE FUNCTION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RIGIDITY;
TREMOR;
DRUG ADMINISTRATION;
DRUG EFFECT;
EARLY DIAGNOSIS;
HUMAN;
METABOLISM;
NEUROLOGIC EXAMINATION;
NOTE;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
ANTIPARKINSON AGENT;
DOPAMINE;
ANTIPARKINSON AGENTS;
BASAL GANGLIA;
DISEASE PROGRESSION;
DOPAMINE;
DRUG ADMINISTRATION SCHEDULE;
EARLY DIAGNOSIS;
HUMANS;
NEUROLOGIC EXAMINATION;
PARKINSON DISEASE;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK ASSESSMENT;
|
EID: 44449157222
PISSN: 00223050
EISSN: 1468330X
Source Type: Journal
DOI: 10.1136/jnnp.2008.144741 Document Type: Editorial |
Times cited : (6)
|
References (4)
|